Al B. Benson

Active 1991–2025

Also published as
Al B Benson
242
Papers
69,681
Citations
134
h-index
232
i10-index

Citations

Citations per year for Al B. Benson1939: 1 citations1943: 1 citations1974: 1 citations1979: 5 citations1981: 1 citations1984: 1 citations1987: 1 citations1990: 1 citations1991: 1 citations1992: 1 citations1993: 2 citations1994: 4 citations1995: 4 citations1996: 4 citations1997: 11 citations1998: 7 citations1999: 17 citations2000: 35 citations2001: 46 citations2002: 89 citations2003: 102 citations2004: 112 citations2005: 187 citations2006: 194 citations2007: 240 citations2008: 312 citations2009: 296 citations2010: 400 citations2011: 442 citations2012: 446 citations2013: 454 citations2014: 482 citations2015: 452 citations2016: 429 citations2017: 467 citations2018: 496 citations2019: 1,909 citations2020: 2,172 citations2021: 2,116 citations2022: 1,609 citations2023: 1,231 citations2024: 2,092 citations2025: 975 citations2026: 27 citations1940–1942: no citations, so these years are not shown1944–1973: no citations, so these years are not shown1975–1978: no citations, so these years are not shown1980: no citations, so this year is not shown1982–1983: no citations, so these years are not shown1985–1986: no citations, so these years are not shown1988–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,771 citing papers, 24.9% of this breakdownChina: 2,870 citing papers, 12.4% of this breakdownItaly: 1,508 citing papers, 6.5% of this breakdownGermany: 1,267 citing papers, 5.5% of this breakdownUnited Kingdom: 1,177 citing papers, 5.1% of this breakdownFrance: 1,018 citing papers, 4.4% of this breakdownJapan: 972 citing papers, 4.2% of this breakdownNetherlands: 825 citing papers, 3.5% of this breakdownCanada: 755 citing papers, 3.2% of this breakdownSpain: 727 citing papers, 3.1% of this breakdownSouth Korea: 582 citing papers, 2.5% of this breakdownAustralia: 566 citing papers, 2.4% of this breakdown
0%24.9%Other 22.3%

Fields

  • Medicine79.3%
  • Biochemistry, Genetics and Molecular Biology14.3%
  • Immunology and Microbiology1.5%
  • Economics, Econometrics and Finance1%
  • Engineering0.9%
  • Computer Science0.5%
  • Other2.5%

Topics

  • Pancreatic and Hepatic Oncology Research5.3%
  • Colorectal Cancer Treatments and Studies5.2%
  • Hepatocellular Carcinoma Treatment and Prognosis4.8%
  • Colorectal Cancer Surgical Treatments4%
  • Neuroendocrine Tumor Research Advances3.6%
  • Cholangiocarcinoma and Gallbladder Cancer Studies3.2%
  • Other73.9%

Coauthors

All papers

Open in search
  1. Phase 3 Trial of 177 Lu-Dotatate for Midgut Neuroendocrine Tumors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas Thevenet, Jack L. Erion, Philippe Ruszniewski, Dik J. Kwekkeboom, Eric P. Krenning - New England Journal of Medicine 2017 cited by 3,178

  2. Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Charles Schneider, David Shibata, John M. Skibber, Constantinos T. Sofocleous, Elena M. Stoffel, Eden Stotsky‐Himelfarb, Christopher G. Willett, Kristina M. Gregory, Lisa A. Gurski - Journal of the National Comprehensive Cancer Network 2021 cited by 1,748

  3. Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2020 cited by 1,125

  4. Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeanne Shen, Charles M. Vollmer, Robert A. Wolff, Brian M. Wolpin, Beth Lynn, Giby V. George - Journal of the National Comprehensive Cancer Network 2021 cited by 1,286

  5. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Demetris Papamichael, George Pentheroudakis, Per Pfeiffer, Timothy Price, Cornelis J.A. Punt, Jens Ricke, A. Roth, Ramón Salazar, Werner Scheithauer, Hans‐Joachim Schmoll, Josep Tabernero, Julien Taı̈eb, Sabine Tejpar, Harpreet Wasan, Takayuki Yoshino, Aziz Zaanan, Dirk Arnold - Annals of Oncology 2016 cited by 3,449

  6. Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Leonard B. Saltz, Charles Schneider, David Shibata, John M. Skibber, Constantinos T. Sofocleous, Eden Stotsky‐Himelfarb, Anna Tavakkoli, Christopher G. Willett, Kristina M. Gregory, Lisa A. Gurski - Journal of the National Comprehensive Cancer Network 2022 cited by 819

  7. Treatment of Metastatic Colorectal Cancer: ASCO Guideline

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 cited by 602

  8. Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jean‐Nicolas Vauthey, Alan P. Venook, Adam C. Yopp, Nicole R. McMillian, Cindy Hochstetler, Susan Darlow - Journal of the National Comprehensive Cancer Network 2021 cited by 1,041

  9. Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , - JAMA 2017 cited by 893

  10. Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nikolaos A. Trikalinos, N. Uboha, Namrata Vijayvergia, Terence Z. Wong, Beth Lynn, Cindy Hochstetler - Journal of the National Comprehensive Cancer Network 2021 cited by 602

  11. HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology

    Authors: , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 cited by 434

  12. ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fang‐Shu Ou, Laura Porter, Kanwal Raghav, Deborah Schrag, Aaron J. Scott, Qian Shi, John H. Strickler, Alan P. Venook, Rona Yaeger, Greg Yothers, Y. Nancy You, Jason A. Zell, Scott Kopetz - Nature Reviews Clinical Oncology 2020 cited by 365

  13. Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , - Gastroenterology 2016 cited by 679

  14. NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sean M. Ronnekleiv‐Kelly, Vaibhav Sahai, Gagandeep Singh, Stacey Stein, Anita Turk, Jean‐Nicolas Vauthey, Alan P. Venook, Adam C. Yopp, Nicole R. McMillian, Ryan Schonfeld, Cindy Hochstetler - Journal of the National Comprehensive Cancer Network 2023 cited by 206

  15. Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Barbara Segarra-Vasquez, Jen Hanley Williams, J.E. Caerwyn Williams, Karen M. Winkfield, Eddy S. Yang, Victoria Zwicker, Lori J. Pierce - Journal of Clinical Oncology 2022 cited by 240

  16. Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher G. Willett, Evan Wuthrick, Kristina M. Gregory, Lisa Gurski, Deborah A. Freedman-Cass - Journal of the National Comprehensive Cancer Network 2018 cited by 994

  17. NCCN Guidelines Insights: Colon Cancer, Version 2.2018

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elena M. Stoffel, Eden Stotsky‐Himelfarb, Christopher G. Willett, Evan Wuthrick, Kristina M. Gregory, Deborah A. Freedman-Cass - Journal of the National Comprehensive Cancer Network 2018 cited by 1,029

  18. A Phase II Randomized, Double-Blind, Placebo-Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First-Line Treatment of Pancreatic Adenocarcinoma

    Authors: , , , , , , - The Oncologist 2017 cited by 176

  19. Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Katrina S. Pedersen, Leonard B. Saltz, Charles Schneider, David Shibata, Benjamin D. Shogan, John M. Skibber, Constantinos T. Sofocleous, Anna Tavakkoli, Christopher G. Willett, Christina Wu, Lisa A. Gurski, Jenna Snedeker, Frankie Jones - Journal of the National Comprehensive Cancer Network 2024 cited by 308

  20. Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 cited by 294

  21. Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sarah P. Thayer, Colin D. Weekes, Robert A. Wolff, Brian M. Wolpin, Jennifer L. Burns, Susan Darlow - Journal of the National Comprehensive Cancer Network 2017 cited by 1,030

  22. HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology

    Authors: , , , , , , , , , , , , , , - Archives of Pathology & Laboratory Medicine 2016 cited by 246

  23. Ipilimumab and Gemcitabine for Advanced Pancreatic Cancer: A Phase Ib Study

    Authors: , , , , , , - The Oncologist 2019 cited by 195

  24. Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres: A Comprehensive Report of Long-term Outcomes

    Authors: , , , , , , , , , , , , , , , , , - Gastroenterology 2009 cited by 1,067